Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: AstraZeneca Pharmaceuticals
Current Parent Company: AstraZeneca
Penalty: $68,500,000
Year: 2011
Date: March 10, 2011
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal: Improper Drug Marketing
Violation Description: AstraZeneca Pharmaceuticals agreed to pay $68.5 million to settle multistate litigation alleging unfair and deceptive practices in its marketing of the antipsychotic drug Seroquel, including promotion of the drug for unapproved uses, failure to adequately disclose potential side effects to health care providers, and withholding of scientific studies that called into question the drug's safety and efficacy.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.